Interesting news and PAA obviously have a long and fruitful working relationship with ONJCRI.
Quite frankly the positivity of the science over a number of years as evident from various independent institutes/bodies is absolutely overwhelming but adds to the frustration of what appears to be lack of progress through the clinical trial phases.
As I believe PAA and its "wonder" drug MPL have achieved a major milestone and as such turned the corner with the recent ONJCRI announcement I am holding on tight for the day when the PAA SP explodes...just opining for the sake of it!!!
Ann: ONJCRI Evaluates Monepantel Anti-Cancer Mechanism, page-90
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $60.84K | 317.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 120380 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 22618 | 3 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |